Last reviewed · How we verify

Trypsin-Chymotrypsin

Dow University of Health Sciences · FDA-approved active Small molecule

Trypsin and chymotrypsin are proteolytic enzymes that break down proteins and fibrin to reduce inflammation, improve tissue healing, and enhance absorption of other drugs.

Trypsin and chymotrypsin are proteolytic enzymes that break down proteins and fibrin to reduce inflammation, improve tissue healing, and enhance absorption of other drugs. Used for Inflammation and swelling reduction, Wound healing and tissue repair, Digestive enzyme supplementation.

At a glance

Generic nameTrypsin-Chymotrypsin
Also known asChymoral Forte
SponsorDow University of Health Sciences
Drug classProteolytic enzyme combination
TargetProtein substrates and fibrin
ModalitySmall molecule
Therapeutic areaInflammation, Wound healing, Digestive disorders
PhaseFDA-approved

Mechanism of action

This combination of serine proteases works by digesting denatured proteins, fibrin deposits, and inflammatory exudates at sites of injury or inflammation. By clearing proteinaceous debris and reducing local inflammation, these enzymes promote tissue repair and can enhance the bioavailability of co-administered medications. The enzymes are typically used topically or systemically for their anti-inflammatory and proteolytic properties.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results